Dr. Ian Joseph Penniston, D.O. Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 |
Amir K. Nicknam, M.D. Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 151 W Brooks Ave, Suite A, North Las Vegas, NV 89030 Phone: 615-778-4066 Fax: 615-778-9114 |
Judith L Salz, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 3945 W Cheyenne Ave, Ste 208, North Las Vegas, NV 89032 Phone: 702-648-8116 Fax: 702-648-8259 |
Dr. William Seaver Hill, M.D., M.P.H. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9013 |
Dr. Jeff C Moon, D.O. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 2621 Losee Rd, North Las Vegas, NV 89030 Phone: 702-295-6566 Fax: 702-295-4323 |
News Archive
Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs.
Household investigations for suspected child maltreatment by Child Protective Services may not be associated with improvements in common, modifiable risk factors including social support, family functioning, poverty and others, according to a report in the October issue of Archives of Pediatrics and Adolescent Medicine, one of the JAMA/Archives journals.
Arizona State University has been awarded a $7.7 million grant for the next five years from the National Institute of General Medical Sciences, part of the National Institutes of Health, to unravel the structures of membrane proteins that play a key role in protection against infectious diseases.
People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
The U.S. Food and Drug Administration today approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS).
› Verified 2 days ago